Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharm Biopharm ; 139: 68-75, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30849430

ABSTRACT

The penetration of topically applied tacrolimus formulated in micelles into murine skin is reported, measured by X-ray microscopy. Tacrolimus and micelles are probed for the first time by this high spatial resolution technique by element-selective excitation in the C 1s- and O 1s-regimes. This method allows selective detection of the distribution and penetration depth of drugs and carrier molecules into biologic tissues. It is observed that small, but distinct quantities of the drug and micelles, acting as a drug carrier, penetrate the stratum corneum. A comparison is made with the paraffin-based commercial tacrolimus ointment Protopic®, where local drug concentrations show to be low. A slight increase in local drug concentration in the stratum corneum is observed, if tacrolimus is formulated in micelles, as compared to Protopic®. This underscores the importance of the drug formulations for effective drug delivery. Time-resolved penetration shows presence of drug in the stratum corneum 100 min after formulation application, with penetration to deeper skin layers at 1000 min. High resolution micrographs give indications for a penetration pathway along the lipid membranes between corneocytes, but also suggest that the compound may penetrate corneocytes.


Subject(s)
Drug Carriers/chemistry , Skin/metabolism , Tacrolimus/pharmacokinetics , Administration, Cutaneous , Animals , Mice , Micelles , Microscopy/methods , Ointments , Permeability , Skin/ultrastructure , Skin Absorption , Tacrolimus/administration & dosage , Time Factors , Tissue Distribution , X-Rays
2.
Eur J Pharm Biopharm ; 118: 30-37, 2017 Sep.
Article in English | MEDLINE | ID: mdl-27998691

ABSTRACT

The penetration of dexamethasone into human skin ex vivo is reported. X-ray microscopy is used for label-free probing of the drug and quantification of the local drug concentration with a spatial resolution reaching 70±5nm. This is accomplished by selective probing the dexamethasone by X-ray absorption. Varying the penetration time between 10min and 1000min provides detailed information on the penetration process. In addition, the stratum corneum has been damaged by tape-stripping in order to determine the importance of this barrier regarding temporally resolved drug penetration profiles. Dexamethasone concentrations distinctly vary, especially close to the border of the stratum corneum and the viable epidermis, where a local minimum in drug concentration is observed. Furthermore, near the basal membrane the drug concentration strongly drops. High spatial resolution studies along with a de-convolution procedure reveal the spatial distribution of dexamethasone in the interspaces between the corneocytes consisting of stratum corneum lipids. These results on local drug concentrations are interpreted in terms of barriers affecting the drug penetration in human skin.


Subject(s)
Dexamethasone/pharmacology , Epidermis/metabolism , Microscopy/methods , Skin Absorption , Spectrum Analysis/methods , Administration, Cutaneous , Female , Healthy Volunteers , Humans , Lipids/chemistry , X-Rays
3.
J Control Release ; 242: 64-70, 2016 11 28.
Article in English | MEDLINE | ID: mdl-27568290

ABSTRACT

Label-free detection of core-multishell (CMS) nanocarriers and the anti-inflammatory drug dexamethasone is reported. Selective excitation by tunable soft X-rays in the O 1s-regime is used for probing either the CMS nanocarrier or the drug. Furthermore, the drug loading efficiency into CMS nanocarriers is determined by X-ray spectroscopy. The drug-loaded nanocarriers were topically applied to human skin explants providing insights into the penetration and drug release processes. It is shown that the core-multishell nanocarriers remain in the stratum corneum when applied for 100min to 1000min. Dexamethasone, if applied topically to human ex vivo skin explants using different formulations, shows a vehicle-dependent penetration behavior. Highest local drug concentrations are found in the stratum corneum as well as in the viable epidermis. If the drug is loaded to core-multishell nanocarriers, the concentration of the free drug is low in the stratum corneum and is enhanced in the viable epidermis as compared to other drug formulations. The present results provide insights into the penetration of drug nanocarriers as well as the mechanisms of controlled drug release from CMS nanocarriers in human skin. They are also compared to related work using dye-labeled nanocarriers and dyes that were used as model drugs.


Subject(s)
Dexamethasone/administration & dosage , Drug Carriers/chemistry , Drug Delivery Systems , Nanoparticles , Administration, Cutaneous , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/pharmacokinetics , Biological Transport , Chemistry, Pharmaceutical/methods , Delayed-Action Preparations , Dexamethasone/pharmacokinetics , Drug Liberation , Humans , Microscopy, Atomic Force/methods , Skin/metabolism , Skin Absorption , Time Factors , X-Ray Absorption Spectroscopy/methods
4.
Anal Chem ; 87(12): 6173-9, 2015 Jun 16.
Article in English | MEDLINE | ID: mdl-25942614

ABSTRACT

Selective probing of dexamethasone in excised human skin using soft X-ray spectromicroscopy provides quantitative concentration profiles as well as two-dimensional drug distribution maps. Element- and site-selective excitation of dexamethasone at the oxygen K-edge with the lateral step width adjusted to 1 µm provides detailed information on the location of the drug in the different skin layers. The key of this work is to probe dexamethasone selectively at the carbonyl site (C3) by the O 1s → π* transition, providing also a most efficient way to quantify the drug concentration as a function of penetration depth in correlation with structural properties of the skin containing carboxyl and amide oxygen sites occurring at higher transition energy than dexamethasone. Following drug exposure for 4 h, the glucocorticoide is located in about equal amounts in the stratum corneum, the outermost horny layer of skin, and in the viable epidermis, whereas in the dermis no dexamethasone is detected. In the stratum corneum, most of the lipophilic drug is found in regions between corneocytes, where epidermal lipids are dominating.


Subject(s)
Dexamethasone/pharmacokinetics , Skin/chemistry , Dexamethasone/chemistry , Healthy Volunteers , Humans , Molecular Conformation , Spectrum Analysis , X-Rays
5.
Eur Cell Mater ; 22: 26-42, 2011 Jul 06.
Article in English | MEDLINE | ID: mdl-21732280

ABSTRACT

e assumption that mesenchymal stromal cell (MSC)-based-therapies are capable of augmenting physiological regeneration processes has fostered intensive basic and clinical research activities. However, to achieve sustained therapeutic success in vivo, not only the biological, but also the mechanical microenvironment of MSCs during these regeneration processes needs to be taken into account. This is especially important for e.g., bone fracture repair, since MSCs present at the fracture site undergo significant biomechanical stimulation. This study has therefore investigated cellular characteristics and the functional behaviour of MSCs in response to mechanical loading. Our results demonstrated a reduced expression of MSC surface markers CD73 (ecto-5'-nucleotidase) and CD29 (integrin ß1) after loading. On the functional level, loading led to a reduced migration of MSCs. Both effects persisted for a week after the removal of the loading stimulus. Specific inhibition of CD73/CD29 demonstrated their substrate dependent involvement in MSC migration after loading. These results were supported by scanning electron microscopy images and phalloidin staining of actin filaments displaying less cell spreading, lamellipodia formation and actin accumulations. Moreover, focal adhesion kinase and Src-family kinases were identified as candidate downstream targets of CD73/CD29 that might contribute to the mechanically induced decrease in MSC migration. These results suggest that MSC migration is controlled by CD73/CD29, which in turn are regulated by mechanical stimulation of cells. We therefore speculate that MSCs migrate into the fracture site, become mechanically entrapped, and thereby accumulate to fulfil their regenerative functions.


Subject(s)
5'-Nucleotidase/physiology , Biomechanical Phenomena , Cell Movement , Integrin beta1/physiology , Mesenchymal Stem Cells/cytology , Regeneration , Cells, Cultured , Down-Regulation , Fracture Healing , Fractures, Bone/therapy , GPI-Linked Proteins/physiology , Humans , Mesenchymal Stem Cells/physiology , Wound Healing
6.
J Colloid Interface Sci ; 234(2): 445-447, 2001 Feb 15.
Article in English | MEDLINE | ID: mdl-11161533

ABSTRACT

Density measurements of aqueous albumin solutions as a function of concentration and temperature are reported. The solvents were H(2)O, D(2)O, and a physiological H(2)O-based buffer. An anomaly of the density at very small concentrations of albumin in D(2)O was found. Furthermore, the partial specific volume of albumin is remarkably different in D(2)O and H(2)O. We attribute both effects to structural differences of the solvents. Copyright 2001 Academic Press.

SELECTION OF CITATIONS
SEARCH DETAIL
...